source
- AstraZeneca lifts UK investment pause, pledges £300 million for new office expansionAstraZeneca announced on Wednesday that it is ending its pause on UK investment and will allocate £300 million to complete construction of a new office facility. The funding is intended to expand t…
- Chiesi to acquire KalVista Pharmaceuticals for $1.9 billion in cash dealItalian pharma Chiesi announced it will purchase commercial biotech KalVista Pharmaceuticals. The transaction is valued at about $1.9 billion, with Chiesi paying $27 per share in cash. The acquis…